ABBREVIATIONSBMmarrowCBB(s)cord blood bank(s)CBU(s)cord blood unit(s)DLI(s)donor lymphocyte infusion(s)INTinternationalOMOneMatchPBSC(s)peripheral blood stem/progenitor cell(s)TNCtotal nucleated cell countIncreasing numbers of patients are deemed eligible for hematopoietic cell transplantation, including older patients with comorbidities, due to improved supportive care and the introduction of reduced‐intensity conditioning regimens. Moreover, evolving indications for allogeneic transplant include acute myeloid leukemia at earlier stages of disease, myelodysplastic syndrome, and myeloproliferative disorders. As the number of available sibling donors declines due to smaller family size in recent decades and potential issues related to donor eligibility in older siblings, transplant centers continue to rely heavily on unrelated donors and cord blood units (CBUs). Canadian transplant centers typically prefer allele matching of prospective donors at HLA‐A, ‐B, ‐C, ‐DRB1, and ‐DQB1 loci, with the hope of identifying 10 of 10 HLA‐matched donors. While HLA match level between donor/recipient pairs is considered to be the dominant factor in the selection of unrelated donors, the extent to which additional factors such as sex and donor age influence donor choice remains unclear and the impact of patient ethnicity on donor matching in Canada is unknown. While OneMatch (OM) search specialists can assist in allogeneic search strategies, donor selection is ultimately the responsibility of Canadian transplant centers.With
Transfusion – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera